EXPLAINED: Spyre | Vintage Vibes

This Stock’s Already Up Nearly 600% Over the Past Year

Spyre Therapeutics (SYRE) has surged more than 565% over the past year, driven by strong technical momentum. Shares are trading at a new 3-year high. SYRE maintains a 100% “Buy” technical opinion from Barchart. Short interest is elevated at 13.81% of float, highlighting volatility and the need for disciplined risk...

Barchart · Aug 19

The Other Side of College Football’s Game Changer: The NIL Collective

The groups are well known for their recruiting influence and murky legality. But their impact extends to current athletes, too.

Sports Illustrated · Aug 10, 2022